Cholinergic neuronal deficits in CADASIL

Stroke

Volumn 38, Issue 1, 2007, Pages 188-191

  Keverne, Jessica S ^a   Low, Wee Chuang R ^a   Ziabreva, Iryna ^a   Court, Jenny A ^a   Oakley, Arthur E ^a   Kalaria, Raj N ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

CADASIL; Cholinergic neurones; Cognitive impairment; Small vessel disease; Vascular dementia

Indexed keywords

CHOLINE ACETYLTRANSFERASE; NEUROTROPHIN RECEPTOR; PROTEIN P75;

ADULT; AGED; ARTICLE; CADASIL; CELLULAR DISTRIBUTION; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEYNERT BASAL NUCLEUS; NERVE FUNCTION; NERVE LESION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; BASAL NUCLEUS OF MEYNERT; CADASIL; CEREBRAL ARTERIES; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DOWN-REGULATION; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURAL PATHWAYS; RECEPTOR, NERVE GROWTH FACTOR; TEMPORAL LOBE;

EID: 33845936744     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000251787.90695.05     Document Type: Article

References (15)

1. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X. Clinical spectrum of CADASIL: A study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-939.
2. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371-384.
3. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
4. Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology. 2003;60:1183-1185.
5. Erkinjuntti T, Roman G, Gauthier S, Feldman H, Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke. 2004;35:1010-1017.
6. Togashi H, Kimura S, Matsumoto M, Yoshioka M, Minami M, Saito H. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke. 1996;27:520-525.
7. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiology of Aging. 2006;27:1769-1785.
8. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke. 2003;34:2440-2444.
9. Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C. Absence of cholinergic deficits in "pure" vascular dementia. Neurology. 2005;64:132-133.
10. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75-80.
11. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121:2249-2257.
12. Tomimoto H, Ohtani R, Shibata M, Nakamura N, Ihara M. Loss of cholinergic pathways in vascular dementia of the binswanger type. Dementia and Geriatric Cognitive Disorders. 2005;19:282-288.
13. Swartz RH, Sahlas DJ, Black SE. Strategic involvement of cholinergic pathways correlates with visuospatial and executive dysfunction: does the location of white matter signal hyperintensities matter? J Stroke Cerebrovasc Dis. 2003;12:29-36.
14. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628-634.
15. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34:2323-2330.